太美医疗科技（股票代码：02576）于2026年7月23日发布公告，披露公司当日在香港联交所场内回购67.96万股H股，占回购前已发行股份约0.34%。每股回购价格介乎5.44港元至5.77港元，合共付出的价格约为377.23万港元。
本次回购完成后，公司的已发行股份（不包括库藏股份）由7月22日的197,175,733股减少至196,496,133股，库藏股份则由3,416,800股增至4,096,400股，总发行股份数维持在200,592,533股。公告显示，公司此前于2026年6月23日获得购回授权，可回购股份总数为20,017,153股，截至目前已合计购回3,675,400股，占授权时已发行股份数约1.84%。
公司确认本次回购行为符合香港联交所证券上市规则及相关法规要求。公告由执行董事及联席公司秘书倪晓梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.